Urticaria Industry Anticipated to Expand at 17.7% CAGR During the Forecast Period

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Urticaria Market Between 2025 And 2029?

The market for urticaria has experienced rapid expansion over recent years. It is projected to grow from $4.03 billion in 2024 to $4.76 billion in 2025, at a compound annual growth rate (CAGR) of 18.1%. The historic growth can be attributed to factors such as the increasing prevalence of allergies, rising awareness of skin disorders, advancements in immunology and biologics, growing demand for antihistamines, and improving diagnostic techniques.

The urticaria market is anticipated to experience substantial growth in the upcoming years. It is projected to expand to $9.14 billion by 2029, achieving a compound annual growth rate (CAGR) of 17.7%. This expected growth during the forecast period is driven by factors such as an increase in chronic urticaria cases, the wider adoption of biologic therapies, greater investments in dermatology research, improved access to advanced allergy diagnostics, and the ongoing development of personalized medicine. Significant trends in the forecast period include the emergence of AI-powered diagnostic tools, the creation of novel biologics, advancements in personalized immunotherapy, the use of wearable skin monitoring devices, and the integration of telemedicine for allergy management.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23554&type=smp

Which Drivers Are Impacting The Urticaria Market?

Enhanced understanding and management of skin diseases are anticipated to boost the growth of the urticaria market in the coming years. Elevated pollution levels contribute to an increase in skin allergies and conditions, thereby stimulating the demand for greater awareness and advanced therapeutic options. Urticaria itself contributes to skin disease awareness and treatment by illustrating immune system responses, driving research, improving diagnostics, and advancing targeted therapies. For instance, in February 2024, The Skin Cancer Foundation, a US-based nonprofit, reported that 1 in 5 Americans develop skin cancer by age 70, with over 2 deaths occurring every hour in the U.S. This information emphasizes the urgent requirement for preventive measures, as having five or more sunburns doubles the risk of melanoma. Therefore, increased skin disease awareness and treatment are propelling the expansion of the urticaria market.

What Are The Key Segments In The Urticaria Market?

The urticariamarket covered in this report is segmented –

1) By Type: Acute Urticaria; Chronic Urticaria

2) By Drug Class: Antihistamines; Anti-inflammation Medications; Antidepressants; Monoclonal Antibodies; Other Drug Classes

3) By Route of Administration: Oral; Parenteral; Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy

5) By End-Users: Hospitals; Homecare; Specialty Clinics; Other End-Users

Subsegments:

1) By Acute Urticaria: Allergic Urticaria; Infectious Urticaria; Drug-Induced Urticaria; Contact Urticaria

2) By Chronic Urticaria: Chronic Spontaneous Urticaria (CSU); Chronic Inducible Urticaria (CIndU)

Which Competitive Trends Are Defining The Urticaria Market Structure?

Leading companies in the urticaria market are focusing on developing novel solutions, such as mast cell inhibitor antibodies, to create an advanced therapeutic approach for managing chronic spontaneous urticaria by targeting mast cell activation. A mast cell inhibitor antibody functions as a targeted monoclonal antibody, preventing the activation or degranulation of mast cells by suppressing specific receptors or signaling pathways, thereby diminishing allergic reactions, inflammation, and other mast cell-mediated conditions. For instance, in May 2024, Allakos Inc., a US-based biotechnology company, announced the commencement of a Phase 1 clinical trial for AK006, designed to treat chronic spontaneous urticaria (CSU). This innovative therapy targets both IgE-dependent and IgE-independent mast cell activation pathways, offering potential for broader efficacy in patients resistant to antihistamines or prior biologic treatments. By selectively inhibiting mast cell activity through the Siglec-6 receptor, AK006 aims to provide a more comprehensive and enduring solution for CSU management, signifying a notable progression in urticaria treatment and immunotherapy research.

Who Are The Prominent Global Companies Shaping The Urticaria Market?

Major companies operating in the urticaria market are Sanofi S.A., Novartis AG, GlaxoSmithKline PLC, Roche Holding AG, Viatris Inc., Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Incyte Corporation, Kyowa Kirin Co. Ltd., Dr. Reddy’s Laboratories Ltd, Cipla Ltd., Amneal Pharmaceuticals Inc, Glenmark Pharmaceuticals Ltd, Torrent Pharmaceuticals, Almirall S.A., Argenx SE, BioCryst Pharmaceuticals Inc., Pharvaris NV, Revolution Medicines Inc., Allakos.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/urticaria-global-market-report

How Do Regional Market Performances Compare Within The Urticaria Industry?

North America was the largest region in the urticaria market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the urticaria market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Urticaria Market Report:

https://www.thebusinessresearchcompany.com/customise?id=23554&type=smp

Browse Through More Reports Similar to the Global Urticaria Market 2025, By The Business Research Company

Transdermal Skin Patches Market 2025

https://www.thebusinessresearchcompany.com/report/transdermal-skin-patches-market

Natural Skin Care Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/natural-skin-care-products-global-market-report

Organic Skincare Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/organic-skincare-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795